Related Experiment Videos
Corynebacterium pseudodiphtheriticum: a respiratory tract pathogen
K Ahmed1, K Kawakami, K Watanabe
1Department of Internal Medicine, Nagasaki University, Japan.
Abstract:
From January 1986 through February 1993, there were 16 episodes of respiratory infection due to Corynebacterium pseudodiphtheriticum in 13 patients. The ages of patients ranged from 24 to 77 years; the ratio of male to female patients was 3:1. One patient had three episodes of infection, and another patient had two. In one patient, who died of disseminated intravascular coagulation, the level of IgG was low. One patient was receiving prednisolone when the infection occurred. In two cases a mixed infection with Streptococcus pneumoniae was noted. Sputum cultures yielded C. pseudodiphtheriticum (> or = 10(7) cfu/mL). An increased neutrophil response in the sputum of infected patients was observed. Gram staining and electron microscopy of sputum showed phagocytosis of C. pseudodiphtheriticum by the neutrophils. ELISAs also showed an increase in the level of immunoglobulin against C. pseudodiphtheriticum after infection. Tests for determination of MICs of antibiotics revealed that C. pseudodiphtheriticum isolates were susceptible to ampicillin, amoxycillin/clavulanic acid, cefazolin, cefuroxime, ceftazidime, and imipenem. All strains were resistant to nalidixic acid; borderline susceptibility to ofloxacin, norfloxacin, and ciprofloxacin was noted. We suggest the use of beta-lactam antibiotics in the treatment of infection with C. pseudodiphtheriticum.
Insights
Corynebacterium pseudodiphtheriticum can cause respiratory infections, particularly in older adults. Beta-lactam antibiotics show effectiveness in treating these infections, as indicated by susceptibility tests.
Area of Science:
- Medical Microbiology
- Infectious Diseases
Background:
- Corynebacterium pseudodiphtheriticum is a bacterium that can cause opportunistic infections.
- Respiratory infections are a common concern, especially in vulnerable populations.
Purpose of the Study:
- To investigate the clinical features and treatment outcomes of respiratory infections caused by Corynebacterium pseudodiphtheriticum.
- To determine the antibiotic susceptibility patterns of Corynebacterium pseudodiphtheriticum isolates.
Main Methods:
- Retrospective analysis of 16 infection episodes in 13 patients between 1986 and 1993.
- Sputum culture, Gram staining, electron microscopy, ELISA, and antibiotic susceptibility testing (MICs).
Main Results:
- 16 episodes of respiratory infection occurred in 13 patients (ages 24-77, male:female ratio 3:1).
- Neutrophil response and phagocytosis of C. pseudodiphtheriticum were observed in sputum.
- Isolates were susceptible to beta-lactam antibiotics (ampicillin, amoxycillin/clavulanic acid, cefazolin, cefuroxime, ceftazidime, imipenem) but resistant to nalidixic acid.
Conclusions:
- Corynebacterium pseudodiphtheriticum can cause significant respiratory infections.
- Beta-lactam antibiotics are recommended for treating C. pseudodiphtheriticum infections based on observed susceptibility.